SenesTechSNES
About: SenesTech Inc is a United States-based biotech platform and research company engaged in developing technology for managing animal pest populations through fertility control. The company provides its solutions to the animal market, commercial markets, and food markets. It currently has two product lines of fertility control products: ContraPest and Evolve.
Employees: 23
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
10.52% less ownership
Funds ownership: 11.04% [Q3] → 0.52% (-10.52%) [Q4]
25% less funds holding
Funds holding: 4 [Q3] → 3 (-1) [Q4]
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
88% less capital invested
Capital invested by funds: $148K [Q3] → $17.7K (-$130K) [Q4]
Research analyst outlook
We haven’t received any recent analyst ratings for SNES.
Financial journalist opinion









